# Arbutus Biopharma Corp: Form SC 13D/A, filed May 17, 2024

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: SC 13D/A
- Filed: 2024-05-17
- Accepted by EDGAR: May 17, 2024, 09:03 ET
- Period: not reported
- Accession: 0001193805-24-000672
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000119380524000672/sc13da114125002_05172024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000119380524000672/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000119380524000672/sc13da114125002_05172024.htm

Filed May 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001193805-24-000672. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
